CO2 laser resurfacing of psoriatic plaques: a pilot study.
BACKGROUND AND OBJECTIVE: Laser resurfacing can precisely remove epidermis and papillary dermis, sites pivotal to the pathogenesis of psoriasis. Our objective was to determine the efficacy and safety of superficially ablating carbon dioxide (CO2) lasers for treating isolated, recalcitrant psoriatic plaques. MATERIALS AND METHODS: Twelve adult subjects with stable, plaque-type psoriasis were recruited. In six volunteers, the quadrants received different numbers of passes with a 60 microsec pulsed CO2 (Tru-Pulse) laser. In the remaining patients, one quadrant underwent curettage prior to resurfacing, the second resurfacing with a scanned continuous wave (Sharplan Silktouch) CO2 laser and the last curettage alone. RESULTS: Despite clinical and histological evidence of complete ablation of the epidermis and papillary dermis, most quadrants recurred within 8 weeks. Surprisingly, two patients showed no recurrence after 4 months. CONCLUSION: Ablation of the entire epidermis and papillary dermis with either pulsed or scanned CO2 lasers appears generally ineffective in treating recalcitrant psoriatic plaques, although the clearing seen in two patients suggests potentially successful future research directions.[1]References
- CO2 laser resurfacing of psoriatic plaques: a pilot study. Alora, M.B., Anderson, R.R., Quinn, T.R., Taylor, C.R. Lasers in surgery and medicine. (1998) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
